32 transactions by 14 insiders, from November 21, 2025 to October 1, 2026.
People inside the company. What they do with their own shares is the reason this data exists.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| Kevin M. BrennanSVP | 11 | 4/11 | — | $1K |
| Christopher James FrankenfieldCFO | 4 | 4/4 | — | $5K |
| Katarina LuptakovaCMO | 3 | — | — | — |
| Rene RussoCEO | 3 | — | — | — |
| James Samuel ShannonDir | 2 | — | — | — |
| Yuan XuDir | 1 | — | — | — |
| Daniel J. CurranDir | 1 | — | — | — |
| Akintunde Olatokumbo BelloDir | 1 | — | — | — |
| Yariv HouvrasCMO | 1 | — | — | — |
| Cheryl R. BlanchardDir | 1 | — | — | — |
| Sara BonsteinDir | 1 | — | — | — |
| Aoife BrennanDir | 1 | — | — | — |
| Robert W. RossDir | 1 | — | — | — |
Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| GILEAD SCIENCES, INC.10% | 1 | — | — | — |
32 in total, newest filings first.
| Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|
| Yariv HouvrasCMODERIV | Oct 1 | A | 105,000 | $0.00 | —? |
| Yuan XuDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| James Samuel ShannonDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Robert W. RossDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Daniel J. CurranDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Aoife BrennanDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Sara BonsteinDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Akintunde Olatokumbo BelloDirDERIV | Jun 11 | A | 5,000 | $0.00 | —? |
| Cheryl R. BlanchardDirDERIV | Apr 15 | A | 10,000 | $0.00 | —? |
| James Samuel ShannonDir | Mar 26 | P | 5,000 | $8.79 | $44K? |
| GILEAD SCIENCES, INC.10%DERIV | Feb 13 | P | 3,739,000 | $0.53 | $2.0M? |
| Rene RussoCEODERIV | Jan 1 | M | 44,250 | $0.00 | —? |
| Rene RussoCEODERIV | Dec 31 | A | 1,500,258 | $0.00 | —? |
| Rene RussoCEO | Jan 1 | M | 44,250 | — | — |
| Katarina LuptakovaCMODERIV | Jan 1 | M | 16,625 | $0.00 | —? |
| Katarina LuptakovaCMODERIV | Dec 31 | A | 451,885 | $0.00 | —? |
| Katarina LuptakovaCMO | Jan 1 | M | 16,625 | — | — |
| Christopher James FrankenfieldCFODERIV | Jan 1 | MPLAN | 19,375 | $0.00 | —? |
| Christopher James FrankenfieldCFODERIV | Dec 31 | APLAN | 668,789 | $0.00 | —? |
| Christopher James FrankenfieldCFO | Jan 2 | SPLAN | 7,030 | $0.64 | $5K |
| Christopher James FrankenfieldCFO | Jan 1 | MPLAN | 19,375 | — | — |
| Kevin M. BrennanSVPDERIV | Jan 1 | MPLAN | 5,000 | $0.00 | —? |
| Kevin M. BrennanSVPDERIV | Dec 31 | APLAN | 95,221 | $0.00 | —? |
| Kevin M. BrennanSVP | Jan 2 | SPLAN | 1,826 | $0.64 | $1K |
| Kevin M. BrennanSVP | Jan 1 | MPLAN | 5,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | A | 20,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | D | 20,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | A | 25,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | D | 25,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | A | 55,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | D | 55,000 | — | — |
| Kevin M. BrennanSVPDERIV | Nov 21 | A | 131,700 | $0.00 | —? |